Small-for-gestational-age births in pregnant women with HIV, due to severity of HIV disease, not antiretroviral therapy

Infectious Diseases in Obstetrics and Gynecology

Volumn 2012, Issue , 2012, Pages

  Aaron, Erika ^a   Bonacquisti, Alexa ^a   Mathew, Leny ^b   Alleyne, Gregg ^a   Bamford, Laura P ^a   Culhane, Jennifer F ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BIRTH WEIGHT; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ABUSE; EDUCATIONAL STATUS; FEMALE; FIRST TRIMESTER PREGNANCY; HEALTH BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MARRIAGE; PARITY; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; THIRD TRIMESTER PREGNANCY; URBAN POPULATION; VAGINAL DELIVERY; VIRUS LOAD; HOSPITALIZATION; IMMUNOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; UNITED STATES;

ANTIRETROVIRUS AGENT;

ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES; YOUNG ADULT;

EID: 84863696899     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2012/135030     Document Type: Article

References (32)

1. Whitmore S. K., Zhang X., Taylor A. W., Blair J. M., Estimated number of infants born to HIV-infected women in the United States and five dependent areas, 2006 Journal of Acquired Immune Deficiency Syndromes 2011 57 3 218 222
2. Centers for Disease Control and Prevention, Mother-to-Child (Perinatal) HIV Transmission and Prevention. 2007, http://www.cdc.gov/hiv/topics/perinatal/ resources/factsheets/perinatal.htm
3. Cocroft J. R., Hauck W. W., Cosler L., Turner B. J., The effect of ethnicity and maternal birthplace on small-for-gestational-age deliveries to HIV-infected women Journal of Urban Health 2002 79 1 147 160 (Pubitemid 34478030)
4. Mirpuri J., Jain L., Issues of prematurity and HIV infection Clinics in Perinatology 2010 37 4 887 905
5. Traisathit P., Mary J. Y., Le Cur S., Thantanarat S., Jungpichanvanich S., Pornkitprasarn W., Gomutbutra V., Matanasarawut W., Wannapira W., Lallemant M., Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV Journal of Obstetrics and Gynaecology Research 2009 35 2 225 233
6. Saenger P., Czernichow P., Hughes I., Reiter E. O., Small for gestational age: short stature and beyond Endocrine Reviews 2007 28 2 219 251 (Pubitemid 46984835)
7. McCowan L., Horgan R. P., Risk factors for small for gestational age infants Best Practice and Research 2009 23 6 779 793
8. Elo I. T., Culhane J. F., Kohler I. V., O'Campo P., Burke J. G., Messer L. C., Kaufman J. S., Laraia B. A., Eyster J., Holzman C., Neighbourhood deprivation and small-for-gestational-age term births in the United States Paediatric and Perinatal Epidemiology 2009 23 1 87 96
9. Gardosi J., New definition of small for gestational age based on fetal growth potential Hormone Research 2006 65 3 15 18 (Pubitemid 44689428)
10. Bursac Z., Gauss C. H., Williams D. K., Hosmer D. W., Purposeful selection of variables in logistic regression Source Code for Biology and Medicine 2008 3, article 17
11. Bendel R. B., Afifi A. A., Comparison of stopping rules in forward stepwise regression Journal of the American Statistical Association 1977 72 46 53
12. Mickey R. M., Greenland S., The impact of confounder selection criteria on effect estimation American Journal of Epidemiology 1989 129 1 125 137 (Pubitemid 19030705)
13. Sibiude J., Warszawski J., Tubiana R., Dollfus C., Faye A., Rouzioux C., Teglas J.-P., Ekoukou D., Blanche S., Mandelbrot L., Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clinical Infectious Diseases 2012 54 9 1348 1360
14. Kakkar F., Lamarre V., Soudeyns H., Use of boosted protease inhibitor in pregnancy and risk of prematurity among HIV-exposed uninfected infants: Canada Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections March 2012 Seattle Wash, USA Poster #1026
15. Dennis E. F., Webb D. A., Lorch S. A., Mathew L., Bloch J. R., Culhane J. F., Subjective social status and maternal health in a low income urban population Maternal and Child Health Journal 2011 16 4 834 843
16. Cotter A. M., Garcia A. G., Duthely M. L., Luke B., O'Sullivan M. J., Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? Journal of Infectious Diseases 2006 193 9 1195 1201
17. Newell M.-L., Aebi C., Battegay M., Combination antiretroviral therapy and duration of pregnancy AIDS 2000 14 18 2913 2920 (Pubitemid 32042755)
18. Tuomala R. E., Shapiro D. E., Mofenson L. M., Bryson Y., Culnane M., Hughes M. D., O'Sullivan M. J., Scott G., Stek A. M., Wara D., Bulterys M., Antiretroviral therapy during pregnancy and the risk of an adverse outcome New England Journal of Medicine 2002 346 24 1863 1870 (Pubitemid 34603030)
19. Patel K., Shapiro D. E., Brogly S. B., Livingston E. G., Stek A. M., Bardeguez A. D., Tuomala R. E., Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy Journal of Infectious Diseases 2010 201 7 1035 1044
20. Tuomala R. E., Watts H., Li D., Vajaranant M., Pitt J., Hammill H., Landesman S., Zorrilla C., Thompson B., Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy Journal of Acquired Immune Deficiency Syndromes 2005 38 4 449 473 (Pubitemid 40381556)
21. Szyld E. G., Warley E. M., Freimanis L., Gonin R., Cahn P. E., Calvet G. A., Duarte G., Melo V. H., Read J. S., Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth AIDS 2006 20 18 2345 2353 (Pubitemid 44789537)
22. Kourtis A. P., Schmid C. H., Jamieson D. J., Lau J., Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis AIDS 2007 21 5 607 615
23. Thorne C., Patel D., Newell M. L., Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe AIDS 2004 18 17 2337 2339 (Pubitemid 39620231)
24. Powis K. M., Kitch D., Ogwu A., Hughes M. D., Lockman S., Leidner J., Van Widenfelt E., Moffat C., Moyo S., Makhema J., Essex M., Shapiro R. L., Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy Journal of Infectious Diseases 2011 204 14 506 514
25. Royal College of Obstetricians and Gynaecologists, Pre-eclampsiastudy group consensus statement. 2003, http://www.rcog.org.uk/womens-health/clinical- guidance/pre-eclampsia-study-group-consensus-statement
26. Phillips A. N., Neaton J., Lundgren J. D., The role of HIV in serious diseases other than AIDS AIDS 2008 22 18 2409 2418
27. French M. A., King M. S., Tschampa J. M., Da Silva B. A., Landay A. L., Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T Cells Journal of Infectious Diseases 2009 200 8 1212 1215
28. Hunt P. W., Martin J. N., Sinclair E., Bredt B., Hagos E., Lampiris H., Deeks S. G., T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency vires-infected patients with sustained viral suppression during antiretroviral therapy Journal of Infectious Diseases 2003 187 10 1534 1543 (Pubitemid 36578959)
29. Denney J. M., Nelson E. L., Wadhwa P. D., Waters T. P., Mathew L., Chung E. K., Goldenberg R. L., Culhane J. F., Longitudinal modulation of immune system cytokine profile during pregnancy Cytokine 2011 53 2 170 177
30. Truong H. H. M., Sim M. S., Dillon M., Uittenbogaart C. H., Dickover R., Plaeger S. F., Bryson Y. J., Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers Clinical and Vaccine Immunology 2010 17 12 2024 2028
31. Fiore S., Ferrazzi E., Newell M. L., Trabattoni D., Clerici M., Protease inhibitor-associated increased risk of preterm delivery is an immunological complication of therapy Journal of Infectious Diseases 2007 195 6 914 916 (Pubitemid 46363939)
32. Parekh N., Ribaudo H., Souda S., Chen J., Mmalane M., Powis K., Essex M., Makhema J., Shapiro R. L., Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana International Journal of Gynecology and Obstetrics 2011 115 1 20 25